Test Price
2,800 AED✅ Home Collection Available
C19orf12 Gene (SPG43) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical Assurance & Service Highlights
- ✔ 99.9% Diagnostic Sensitivity – ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- ✔ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily 8 AM to 11 PM.
- ✔ Telephonic Post-Test Clinical Guidance – Expert interpretation of results with genetic counselling support.
- ✔ Insurance Direct Billing – Verify coverage via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The C19orf12 gene NGS test detects pathogenic variants in the C19orf12 gene, confirming autosomal recessive hereditary spastic paraplegia type 43 (SPG43). It utilizes next-generation sequencing for comprehensive single-gene analysis, delivering complete exon coverage with >99% sensitivity. This targeted approach reduces turnaround time and avoids incidental findings.
| Feature | Our Single‑Gene NGS Test | Whole Exome Sequencing (WES) |
|---|---|---|
| Methodology | Targeted Next‑Generation Sequencing | Whole Exome Capture & Sequencing |
| Diagnostic Precision | >99.9% analytical sensitivity for C19orf12 | High coverage but dependent on target enrichment; may miss deep intronic variants. |
| Turnaround Time | 3 – 4 Weeks | 6 – 8 Weeks |
| Incidental Findings | None – analysis limited to C19orf12 gene | Risk of secondary/incidental findings outside primary indication. |
Physician Insight & Safety Protocols
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice – Medication Continuity
⚠ Medication Alert
Do not discontinue any prescribed medication without explicit instruction from your treating physician.
Exclusion Criteria
- Recent blood transfusion or bone marrow transplant (may interfere with DNA source).
- Inability to provide a sterile blood sample or dried blood spot due to severe skin condition.
- Non‑consenting minors – genetic testing must comply with parental consent requirements under UAE Federal Law No. 2 of 2019 and Federal Decree-Law No. 4 of 2016.
Seek emergency care immediately if you experience: sudden loss of mobility, severe muscle spasms, breathing difficulty, or loss of consciousness.
Patient FAQ & Clinical Guidance
1. What is the C19orf12 (SPG43) genetic test and why is it ordered?
This targeted next‑generation sequencing test identifies mutations in the C19orf12 gene, providing a definitive molecular diagnosis for hereditary spastic paraplegia type 43 and informing recurrence risk for family planning.
2. How accurate is the NGS test and how should I prepare?
The test demonstrates >99.9% analytical sensitivity for known pathogenic variants within the C19orf12 coding region, requiring only a standard blood draw or dried blood spot card without fasting.
3. What happens after the test and how will I receive my results?
Results are released within 3–4 weeks via secure electronic delivery, and a complimentary telephonic genetic counselling session is offered to explain the clinical implications.
UAE Regulatory & Data Privacy Adherence
Commitment to Privacy and Security: DNA Labs UAE operates under DHA Facility License No. 1143. All genetic data is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. No genetic information is shared without explicit written consent.
Clinical & Logistical Metadata
| Test Name | C19orf12 Gene (SPG43) Genetic Test – Targeted NGS |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or Dried Blood Spot (FTA Card) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) – Single Gene Analysis |
| ICD-10-CM Code | G11.4 |
| LOINC Code | 83402-5 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians